Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

(2006): Gonzalez-Delgado P+, Allergol Immunopathol (Madr)
34(2), 76
(2006): Hernandez-Salazar A+, Arch Med Res 37(7), 899
(2001): Perez A+, Contact Dermatitis 44, 113 (with allopurinol)
(1999): Benjamin S+, Ann Pharmacother 33, 109
(1999): Wakelin SH+, Clin Exp Dermatol 24, 71
(1996): Webster GF, Philadelphia, PA (from Internet)
(observation)
(1995): Wolkenstein P+, Arch Dermatol 131, 544
(1992): Gross AS+, JAmAcadDermatol27, 781
(1990): Chan HL+, Arch Dermatol 126, 43
(1990): Escallier F+, Rev Med Interne (French) 11, 73
(1989): Chopra R+, Can Med Assoc J 140, 921 (in children)
(1988): Massullo RE+, JAmAcadDermatol19, 358
(1988): Platt R, JInfectDis158, 474
(1986): Davidson NJ+, BMJ 292, 380
(1986): Dikland WJ+, Pediatr Dermatol 3, 135
(1982): Freeman T, Can Med Assoc J 127, 818
Exanthems (>5%)
(2006): Hernandez-Salazar A+, Arch Med Res 37(7), 899
(2005): Reig Rincon de Arellano I+, Allergol Immunopathol (Madr)
33(5), 282
(2003): Leung AK+, Int J Dermatol 42(7), 553
(2003): Zhang YM+, Zhonghua Er Ke Za Zhi 41(2), 135 (2 cases)
(2002): Renn CN+, Br J Dermatol 147(6), 1166 (4 cases, all with
infectious mononucleosis)
(1999): Wakelin SH+, Clin Exp Dermatol 24, 71 (flexural)
(1997): Barbaud AM+, Arch Dermatol 133, 481
(1997): Blumenthal HL, Beachwood, OH (personal case)
(observation)
(1995): Romano A+, Allergy 50, 113
(1995): Wolkenstein P+, Arch Dermatol 131, 544
(1994): Litt JZ, Beachwood, OH (personal case) (observation)
(1993): Fellner MJ, Int J Dermatol 32, 308
(1993): Romano A+, J Invest Allergol Clin Immunol 3, 53
(1990): Pauszek ME, Indiana Med 83, 330
(1989): Battegay M+, Lancet 2, 1100
(1989): Chopra R+, Can Med Assoc J 140, 921 (in children)
(1989): Kennedy C+, Contact Dermatitis 20, 313
(1986): Bigby M+, JAMA 256, 3358 (5.14%)
(1986): de Haan P+, Allergy 41, 75
(1986): Sonntag MR+, Schweiz Med Wochenschr (German)
116, 142 (7%)
(1985): Levine LR, Pediatr Infect Dis 4, 358
(1981): Odegaard OR, Tidsskr Nor Laegeforen (Norwegian)
101, 1973
Exfoliative dermatitis
Fixed eruption
(2001): Agnew KL+, Australas J Dermatol 42(3), 200
(reproducible)
(2000): Brabek E+, Dtsch Med Wochenschr 125(42), 1260
(1998): Mahboob A+, Int J Dermatol 37, 833
(1997): Jimenez I+, Allergol Immunopathol (Madr) 25, 247 (glans
penis)
(1997): Zabawski E, Dallas, TX (from Internet) (observation)
(1995): Arias J+, Clin Exp Dermatol 20, 339
(1995): Dhar S+, Pediatr Dermatol 12, 51 (tongue)
(1994): Gil-Garcia JF+, Med Clin (Barc) (Spanish) 102, 438
(1989): Shuttleworth D, Clin Exp Dermatol 14, 367 (pustular)
(1982): Chowdhury FH, Practitioner 226, 1450 (penile)
Fungal dermatitis
(2004): Leophonte P+, Respir Med 98(8), 708
Hematomas
Intertrigo
(1992): Wolf B+, Acta Derm Venereol (Stockh) 72, 441
Jarisch–Herxheimer reaction
(2003): Leblebicioglu H+, Eur J Clin Microbiol Infect Dis
22(10), 639
(1998): Maloy AL+, J Emerg Med 16, 437
Keratosis pilaris
AMOXICILLIN 31
(1997): Kay M, North Hollywood, CA (from Internet)
(observation)
Pemphigus
(1997): Brenner S+, JAmAcadDermatol36, 919
(1997): Landau M+, Am J Dermatopathol 19, 411
(1991): Escallier F+, Ann Dermatol Venereol (French) 118, 381
(1983): Toan ND+, Ann Dermatol Venereol (French) 110, 917
Perleche
(1982): Arata J+, Jpn J Antibiot (Japanese) 35, 394
Petechiae (Rumpel–Leede sign)
(1992): Gross AS+, JAmAcadDermatol27, 781
Pigmentation
(2003): Zhang YM+, Zhonghua Er Ke Za Zhi 41(2), 135 (2 cases)
Pruritus
(2005): Reig Rincon de Arellano I+, Allergol Immunopathol (Madr)
33(5), 282
(2000): Blumenthal HL, Beachwood, OH (personal case)
(observation)
(1996): Drouet M+, Allerg Immunol Paris (French) 28, 311
(1995): Shelley WB+, Cutis 55, 202 (observation)
(1993): Fellner MJ, Int J Dermatol 32, 308
(1989): Battegay M+, Lancet 2, 1100
Psoriasis
(1993): Litt JZ, Beachwood, OH (from internet) (observation)
(1987): Katz M, JAmAcadDermatol17, 918
Purpura
Pustules
(2000): Whittam LR+, Clin Exp Dermatol 25, 122
(1995): Wolkenstein P+, Arch Dermatol 131, 544
(1992): Trueb R+, Hautarzt (German) 43, 595
(1991): Armster H+, Hautarzt (German) 42, 713
(1991): Roujeau J-C+, Arch Dermatol 127, 1333
(1990): Guy C+, Nouv Dermatol (French) 9, 540
(1989): Epelbaum S+, Pédiatrie (French) 44, 387
(1989): Shuttleworth D, Clin Exp Dermatol 14, 367
Rash (sic) (1–10%)
(1997): Van Buchem FL+, Lancet 349, 683
(1989): Battegay M+, Lancet 2, 1100
(1982): Arata J+, Jpn J Antibiot (Japanese) 35, 394
(1982): Millard G, Scott Med J 27, S35
(1980): Porter J+, Lancet 1, 1037
Side effects (sic)
(1994): Paparello SF+, AIDS 8, 276
Stevens–Johnson syndrome
(1999): Limauro DL+, Ann Pharmacother 33, 560
(1996): Cullimore KC, Westminster, CO (from Internet)
(observation)
(1992): Martin Mateos MA+, J Investig Allergol Clin Immunol
2, 278
(1988): Platt R, JInfectDis158, 474
Toxic epidermal necrolysis
(2004): Najem JC+, Middle East J Anesthesiol 17(6), 1079
(2001): Spies M+, Pediatrics 108, 1162
(1996): Blum L+, JAmAcadDermatol34, 1088
(1996): Surbled M+, AnnFrAnesthReanim(French) 15, 1095
(1993): Correia O+, Dermatology 186, 32
(1993): Romano A+, J Invest Allergol Clin Immunol 3, 53
(1988): Massullo RE+, JAmAcadDermatol19, 358
(1984): Herman TE+, Pediatr Radiol 14, 439
Toxic pustuloderma
(1992): Trueb R+, Hautarzt (German) 43, 595
(1991): Armster H+, Hautarzt (German) 42, 713
Urticaria (1–5%)
(2006): Hernandez-Salazar A+, Arch Med Res 37(7), 899
(2005): Blumenthal H, Beachwood, OH (personal
communication) (observation)
(2003): Zhang YM+, Zhonghua Er Ke Za Zhi 41(2), 135 (2 cases)
(2001): Torres MJ+, Allergy 56(9), 850